C 019: OZONE´S THERAPEUTICAL TARGETS. BASIS OF THEIR PLEIOTROPIC EFFECTS

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S47, 2014 Special supplement with the abstract book of LATINFARMA 2013 Conference C 019: OZONE´S THERAPEUTICAL TARGETS. BASIS OF THEIR PLEIOTROPIC EFFECTS León Fernández OS, Díaz Soto MT, Dranguet Vaillant J. Pharmacy and Food Institute of the University of Havana, Cuba. Abstract Ozone´s therapeutic effects have been demonstrated in … Continue reading C 019: OZONE´S THERAPEUTICAL TARGETS. BASIS OF THEIR PLEIOTROPIC EFFECTS

J Pharm Pharmacogn Res 2(Suppl. 1): S47, 2014

Special supplement with the abstract book of LATINFARMA 2013

Conference

C 019: OZONE´S THERAPEUTICAL TARGETS. BASIS OF THEIR PLEIOTROPIC EFFECTS

León Fernández OS, Díaz Soto MT, Dranguet Vaillant J.

Pharmacy and Food Institute of the University of Havana, Cuba.
Abstract

Ozone´s therapeutic effects have been demonstrated in different diseases which are “seeminlgy” no connected between them. Ozone Oxidative Pre/Postconditioning mechanism showed that ozone administration in low doses and controlled number of treatments was able to increase antioxidant endogenous defence systems therefore a condition in order to expect a therapeutical success with ozonetherapy is that disease has a chronic oxidative stress as component of its etiology so cellular redox balance happen in a therapeutical target of medical ozone. Superoxide dismutase activity is an enzyme which is involved in different diseases, mainly vascular disorders. At the same time, adenosine plays an important role in stress conditions. Both, superoxide dismutase and adenosine, are ubiquitous molecules, achieve its effects through signal transductions and they are modified in specific way by ozonetherapy. Above mentioned ozone´s therapeutical targets are shown through diseases as ischemic syndrome, diabetes and disc hernia which demonstrate ozonetherapy pleiotropic effects.

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio